Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 642.8931 ↑ 0.09%
[as on 21 August, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option and its peers as on 21 August, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 12.89% 0.09% -0.25% 0.58% 4.3% 10.48% 18.93% 14.53% 23.79% 16.04%
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -4.52% -0.31% -1.01% 0.61% 3.5% -6.77% 8.04% 14.28% 16.92% 14.11%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -1.66% 0.07% -0.07% 0.97% 5.68% 1.7% 11.14% 10.16% 14.05% 12.13%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 23.27% -0.4% -0.88% 1.43% 9.85% 19.12% 24.15% 19.25% 26.46% 15.04%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 2.72% -0.03% -1.43% -1.99% 0.11% 4.99% 15.77% 18.42% 20.37% 15.3%
SBI COMMA Fund - DIRECT PLAN - Growth 6.52% -0.2% -0.21% 0.6% 0.22% 12.28% 17.88% 12.65% 20.63% 15.66%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -9.42% 8.09% 4.71% 2.97% 68.53% 23.84% -9.16% 41.33% 35.46% -2.94%

Discrete returns (monthly)

MonthOct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026
Returns 2.24% 0.9% -1.24% -4.66% 5.31% -4.85% 6.03% 2.37% 5.46% 2.71%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.48% 5.94%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.32% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.68%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.31%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.25%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.52%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.03%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.30%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.01%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.74%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.62%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.41%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing2.69%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.66%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.57%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.51%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.42%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.24%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology2.16%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.05%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.01%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.80%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.65%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.58%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology1.54%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.46%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.37%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.07%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.06%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.06%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology1.00%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.92%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.92%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.55%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.43%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.17%
Portfolio data is as on date 31 July, 2026

NAV history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
21 August, 2026642.8931 0.09%
20 August, 2026642.2898 0.12%
19 August, 2026641.5364 -0.28%
18 August, 2026643.3432 0.28%
17 August, 2026641.5439 -0.46%
14 August, 2026644.4846 -0.22%
13 August, 2026645.9200 -0.22%
12 August, 2026647.3344 -0.01%
11 August, 2026647.4211 0.75%
10 August, 2026642.5969 0.1%
7 August, 2026641.9838 -0.01%
6 August, 2026642.0732 0.08%
5 August, 2026641.5674 -0.2%
4 August, 2026642.8853 -0.13%
3 August, 2026643.7372 0.52%
31 July, 2026640.3925 -0.19%
30 July, 2026641.6283 -0.07%
29 July, 2026642.0993 1.2%
28 July, 2026634.5023 0.12%
27 July, 2026633.7712 1.4%
24 July, 2026625.0129 -0.22%
23 July, 2026626.3854 -0.39%
22 July, 2026628.8418 -1.62%
21 July, 2026639.2095 0.34%
20 July, 2026637.0191 1.06%
17 July, 2026630.3621 -1.13%
16 July, 2026637.5345 0.23%
15 July, 2026636.0700 0.26%
14 July, 2026634.4082 0.64%
13 July, 2026630.3743

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 642.8931 as on 21 August, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 12.89% as on 21 August, 2026.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 10.48% as on 21 August, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 18.93% as on 21 August, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.53% as on 21 August, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.53% as on 21 August, 2026.